DGX - Quest Diagnostics Incorporated

NYSE - NYSE Delayed Price. Currency in USD
107.06
-0.05 (-0.05%)
At close: 4:05PM EST
Stock chart is not supported by your current browser
Previous Close107.11
Open106.93
Bid106.45 x 800
Ask107.04 x 1000
Day's Range105.72 - 107.10
52 Week Range82.59 - 108.95
Volume1,328,961
Avg. Volume812,758
Market Cap14.421B
Beta (5Y Monthly)0.84
PE Ratio (TTM)20.09
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.12 (1.98%)
Ex-Dividend DateJan 11, 2020
1y Target EstN/A
All
News
Press Releases
  • Quest Diagnostics To Release Fourth Quarter And Full Year 2019 Financial Results On January 30
    PR Newswire

    Quest Diagnostics To Release Fourth Quarter And Full Year 2019 Financial Results On January 30

    Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2019 results on Thursday, January 30, 2020, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.

  • Quest Diagnostics To Speak At The 38th Annual J.P. Morgan Healthcare Conference
    PR Newswire

    Quest Diagnostics To Speak At The 38th Annual J.P. Morgan Healthcare Conference

    Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 38th Annual J. P. Morgan Healthcare Conference in San Francisco. Steve Rusckowski, Chairman, President and CEO and Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, January 14, 2020 at 7:30 p.m. Eastern Time. Mr. Rusckowski and Mr. Guinan also will participate in a Q&A; session moderated by the host analyst.

  • Quest Diagnostics Prices $800 Million of Senior Notes
    PR Newswire

    Quest Diagnostics Prices $800 Million of Senior Notes

    Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $800 million aggregate principal amount of its 2.950% senior notes due 2030 under the Quest Diagnostics' shelf registration statement.

  • Quest Diagnostics Declares Quarterly Cash Dividend
    PR Newswire

    Quest Diagnostics Declares Quarterly Cash Dividend

    SECAUCUS, N.J. , Nov. 20, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly ...

  • HDL Cholesterol Function Lab Test Offers Novel Insight into Cardiovascular Disease Risk, Reports Quest Diagnostics at American Heart Association 2019 Scientific Sessions
    PR Newswire

    HDL Cholesterol Function Lab Test Offers Novel Insight into Cardiovascular Disease Risk, Reports Quest Diagnostics at American Heart Association 2019 Scientific Sessions

    Other Company Research Demonstrates the Value of Diagnostic Insights in Early Cardiovascular Disease Detection in Clinical and Workplace Settings SECAUCUS, N.J. , Nov. 14, 2019 /PRNewswire/ -- A laboratory ...

  • Quest Diagnostics Earns Gold Status in American Heart Association's 2019 Workplace Health Achievement Index
    PR Newswire

    Quest Diagnostics Earns Gold Status in American Heart Association's 2019 Workplace Health Achievement Index

    SECAUCUS, N.J., Nov. 5, 2019 /PRNewswire/ -- Quest Diagnostics (DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2019 Workplace Health Achievement Index, ranking the company's workplace health initiative among the best in the nation. 2019 marks the second year in a row that Quest has earned this distinction. The Index uses science-based best practices to evaluate the overall quality and comprehensiveness of workplace health programs.

  • Quest Diagnostics Reports Third Quarter 2019 Financial Results
    PR Newswire

    Quest Diagnostics Reports Third Quarter 2019 Financial Results

    - Third quarter revenues of $1.96 billion , up 3.5% from 2018 - Third quarter reported diluted earnings per share from continuing operations ("EPS") of $1.56 , up 2.8% from 2018; and adjusted ...

  • ACCESSWIRE

    Quest Diagnostics, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / October 22, 2019 / Quest Diagnostics, Inc. (NYSE: DGX ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on October 22, 2019 at 8:30 ...

  • PR Newswire

    Majority of Physicians Fear Another Prescription Drug Crisis, Finds New Quest Diagnostics Health Trends™ Report

    SECAUCUS, N.J., Oct. 16, 2019 /PRNewswire/ -- Most primary care physicians (62%) fear the opioid drug crisis will be traded for a new prescription drug crisis and nearly three quarters (72%) worry that chronic pain patients will turn to illicit drugs if they do not have access to prescription opioids, according to a new Health Trends™ report from Quest Diagnostics (DGX). Seventy percent of primary care physicians wish they had more training on how to taper their patients off opioids.

  • Quest Diagnostics To Release Third Quarter 2019 Financial Results On October 22
    PR Newswire

    Quest Diagnostics To Release Third Quarter 2019 Financial Results On October 22

    Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.

  • National Business Group on Health Honors Quest Diagnostics with Best Employers: Excellence in Health & Well-Being Award
    PR Newswire

    National Business Group on Health Honors Quest Diagnostics with Best Employers: Excellence in Health & Well-Being Award

    Quest Diagnostics Recognized for Offering One of the Nation's Best Workforce Health and Well-being Initiatives SECAUCUS, N.J. , Sept. 19, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's ...

  • Quest Diagnostics and hc1 Collaborate to Optimize Enterprise-wide Laboratory Testing for Health Systems
    PR Newswire

    Quest Diagnostics and hc1 Collaborate to Optimize Enterprise-wide Laboratory Testing for Health Systems

    Strategic collaboration aims to improve patient care and reduce costs across thousands of health systems nationwide by delivering insights that empower optimal lab testing SECAUCUS, N.J. and INDIANAPOLIS ...

  • Workforce Drug Positivity Increases in More Than One-Third of U.S. Industry Sectors Examined, According to Quest Diagnostics Multi-Year Analysis
    PR Newswire

    Workforce Drug Positivity Increases in More Than One-Third of U.S. Industry Sectors Examined, According to Quest Diagnostics Multi-Year Analysis

    SECAUCUS, N.J., Sept. 11, 2019 /PRNewswire/ -- One third of U.S. industry sectors experienced year-over-year double-digit increases in workforce drug positivity between 2015 and 2018, according to a new analysis of industry-specific data by Quest Diagnostics (DGX), the world's leading provider of diagnostic information services. The Quest Diagnostics Drug Testing Index™ industry analysis of general U.S. workforce urine drug test results shows year-over-year double-digit increases in workplace drug positivity in six of the 17 sectors reported.

  • Quest Diagnostics Names Manuel O. Méndez as New Commercial Leader
    PR Newswire

    Quest Diagnostics Names Manuel O. Méndez as New Commercial Leader

    SECAUCUS, N.J. , Sept. 10, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Manuel O. Méndez has been named Senior ...

  • Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference
    PR Newswire

    Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference

    SECAUCUS, N.J., Aug. 28, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York.  Stephen Rusckowski, Chairman, President and CEO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.

  • Quest Diagnostics to Speak at the Baird 2019 Global Healthcare Conference
    PR Newswire

    Quest Diagnostics to Speak at the Baird 2019 Global Healthcare Conference

    SECAUCUS, N.J. , Aug. 23, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the ...

  • Quest Diagnostics Reports Second Quarter 2019 Financial Results
    PR Newswire

    Quest Diagnostics Reports Second Quarter 2019 Financial Results

    - Second quarter revenues of $1.95 billion , up 1.8% from 2018 - Second quarter reported diluted earnings per share from continuing operations ("EPS") of $1.51 , down 3.9% from 2018; and adjusted ...

  • Quest Diagnostics Welcomes New Members to the Global Diagnostics Network (GDN)
    PR Newswire

    Quest Diagnostics Welcomes New Members to the Global Diagnostics Network (GDN)

    SECAUCUS, N.J., July 18, 2019 /PRNewswire/ -- Quest Diagnostics (DGX), the world's leading provider of diagnostic information services, announced today the expansion of the Global Diagnostics Network (GDN), a strategic working group of major diagnostic laboratories collaborating to generate enhanced diagnostics insights to improve the delivery of global healthcare. Regional companies LSI Medience, and Strand Life Sciences join Quest and the charter members -- Al Borg Medical Laboratories, Dasa, GC Labs, Healius, KingMed Diagnostics, SYNLAB – as GDN members.

  • PR Newswire

    Quest Diagnostics Named one of the "Best Places to Work for Disability Inclusion"

    SECAUCUS, N.J. , July 17, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has been named to the 2019 Disability Equality ...

  • Catholic Health Services Partners with Quest Diagnostics to Deliver High-Value, Innovative Laboratory Services
    PR Newswire

    Catholic Health Services Partners with Quest Diagnostics to Deliver High-Value, Innovative Laboratory Services

    SECAUCUS, N.J. and ROCKVILLE CENTRE, N.Y., July 17, 2019 /PRNewswire/ -- Catholic Health Services (CHS), an integrated health care delivery system with a 24% market share on Long Island, is teaming up with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to enhance the quality and value of diagnostic services to patients and their doctors. "We are pleased to partner with Catholic Health Services, a leader in health care delivery on Long Island," said Quest Diagnostics Chairman, President and CEO Steve Rusckowski.

  • PR Newswire

    Sharecare names Quest Diagnostics its preferred laboratory partner to advance digital health management

    ATLANTA, July 12, 2019 /PRNewswire/ -- Sharecare, the digital health company that helps people manage all their health in one place, and Quest Diagnostics (DGX) have formed a collaboration designed to improve digital health and disease management for a range of health care consumers. Sharecare has named Quest its preferred laboratory partner for its comprehensive digital health platform. Sharecare and Quest Diagnostics also intend to jointly explore the development of disease management programs and other services to empower better health.

  • Quest Diagnostics To Release Second Quarter 2019 Financial Results On July 23
    PR Newswire

    Quest Diagnostics To Release Second Quarter 2019 Financial Results On July 23

    Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.